D2 and D1 dopaminergic activity of 7-OH-DPAT-Reference-Cited by-同舟云学术

D2 and D1 dopaminergic activity of 7-OH-DPAT

Published:1996-09 Issue:1 Volume:733 Page:41-45
ISSN:0006-8993
Container-title:Brain Research
language:en
Short-container-title:Brain Research

Author:

Sethy Vimala H.,Ellerbrock Brenda R.,Fici Greg J.,Wu Haiyan

Publisher

Elsevier BV

Subject

Developmental Biology,Clinical Neurology,Molecular Biology,General Neuroscience

Reference27 articles.

1. Behavioral and biochemical effects of the dopamine D3 receptor-selective ligand, 7-OH-DPAT, in the normal and reserpine-treated rat;Ahlenius;Eur. J. Pharmacol.,1994

2. Anesthesia and the responsiveness of individual neurons of the caudate nucleus of the cat to acetylcholine, norepinephrine and dopamine administered by microelectrophoresis;Bloom;J. Pharmacol. Exp. Ther.,1965

3. Comparison between the pharmacology of dopamine receptors mediating the inhibition of cell firing in rat brain slices through substantia nigra pars compacta and ventral tegmental area;Bowery;Br. J. Pharmacol.,1994

4. Behavioral effects of the putative D-3 dopamine receptor agonist 7-OH-DPAT in relation to other ‘D-2 like’ agonists;Daly;Neuropharmacology,1993

5. Pharmacological aspects of R(+)-7-OH-DPAT, a putative dopamine D3 receptor ligand;Damsma;Eur. J. Pharmacol.,1993

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stimulation of 5-HT1A receptor with 8-OH-DPAT inhibits hydrogen peroxide-induced neurotoxicity in cultured rat cortical cells;Pharmacological Research;2005-03

2. Lack of a role for the D3 receptor in clozapine induction of c-fos demonstrated in D3 dopamine receptor-deficient mice;Neuroscience;1999-05

3. Both dopamine and the putative dopamine D3 receptor antagonist PNU-99194A induce a biphasic inhibition of phorbol ester-stimulated arachidonic acid release from CHO cells transfected with the dopamine D3 receptor;Life Sciences;1999-02

4. PNU-99194A: A Preferential Dopamine D3 Receptor Antagonist;CNS Drug Reviews;1998-03

5. D1 dopamine receptor activity of anti-Parkinsonian drugs;Life Sciences;1997-03